Filter
355
Text search:
hypochlorite
Featured
Recommendations
71
New Publications
70
Language
Document type
No document type
164
Guidelines
113
Manuals
27
Studies & Reports
11
Strategic & Response Plan
10
Fact sheets
10
Infographics
8
Situation Updates
6
Training Material
5
Brochures
1
Countries / Regions
India
41
Liberia
18
Nigeria
15
Ethiopia
12
Sierra Leone
11
Kenya
10
Guinea
9
Senegal
9
Mali
9
Western and Central Europe
9
Global
9
Burkina Faso
8
Nepal
8
South Africa
8
Côte d’Ivoire / Ivory Coast
7
Congo, Democratic Republic of
6
Ghana
5
Tanzania
5
Uganda
4
Namibia
4
Eswatini/ Swaziland
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Cameroon
3
Niger
3
Haiti
3
Rwanda
3
Bangladesh
3
Malawi
3
Philippines
2
Zambia
2
Syria
2
Chad
2
Ukraine
2
Colombia
2
Lesotho
2
Myanmar / Burma
2
South–East Asia Region
2
Vietnam
2
USA
1
Zimbabwe
1
Somalia
1
Pakistan
1
Iraq
1
Cambodia
1
Singapore
1
Benin
1
Brazil
1
Latin America and the Carribbean
1
Fiji
1
Venezuela
1
Eastern Europe
1
Palestine
1
Congo-Brazzaville
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
158
Key Resources
43
Clinical Guidelines
36
Pharmacy & Technologies
14
Public Health
9
Women & Child Health
6
Capacity Building
3
Toolboxes
COVID-19
100
Ebola
34
Rapid Response
25
Pharmacy
20
Caregiver
17
Cholera
14
Natural Hazards
12
HIV
9
TB
9
AMR
7
Conflict
6
Specific Hazards
6
NTDs
4
Refugee
1
Planetary Health
1
Infectious diseases are constantly in transition. New diseases develop, known dis-eases become widespread or reemerge, and occasionally a disease is eradicated.Infectious diseases such as HIV, tuberculosis, and cholera are significant causes ofillness and death in many parts of the world. Health car
...
Les maladies infectieuses sont en constante mutation. De nouvelles maladies apparaissent, d’autres qui sont bien connues se propagent ou refont surface, et quelques rares fois, une maladie est éradiquée. Les maladies infectieuses telles que le VIH, la tuberculose et le choléra sont des causes c
...
This document has been prepared based on the evidence currently available about
Coronavirus disease 2019 (COVID-19) transmission (human-to-human transmission via respiratory droplets or direct contact from an infected individual).
It is recommended to use it in conjunction with the published World
...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl
...
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr
...
The protection of children and educational facilities is particularly important. Precautions are necessary to prevent the potential spread of COVID-19 in school settings; however, care must also be taken to avoid stigmatizing students and staff who may have been exposed to the virus. It is important
...
The primary focus of the plan continues to be prevention, preparedness and treatment of the the Novel Coronavirus (COVID-19) outbreak. Central to the plan are the following overall objectives:
To prevent further transmission of COVID-19 in the oPt;
To provide adequate care for patients aff
...
This document aims to support public health preparedness planning and response activities on the safe handling of bodies of deceased persons with suspected or confirmed COVID-19: at the site of death, during transport, storage and preparation before burial/cremation, and during burial/cremation.
Interim Guidance 18th March 2020
COVID-19, a disease caused by a novel corona virus (SARS CoV-2), is currently a pandemic, which produces high morbidity in the elderly and in patients with associated comorbidities. Chronic kidney disease stage-5 (CKD-5) patients on dialysis [maintenance hemodialysis (MHD)or continuous ambulatory pe
...
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age
...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health
...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
The purpose of this document is to provide interim guidance for setting up of quarantine facilities
Accessed: 16.04.2020
The role of environmental contamination in transmission of COVID-19 virus is currently not clear. This protocol has been designed to determine (viable) virus presence and persistence on fomites in various locations where a patient infected with COVID-19 is currently receiving care or being isolated,
...
Accessed: 20.04.2020
